Related references
Note: Only part of the references are listed.DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
GC skew defines distinct RNA polymerase pause sites in CpG island promoters
Wendy A. Kellner et al.
GENOME RESEARCH (2015)
Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation
Tuncay Baubec et al.
NATURE (2015)
Epigenetic reprogramming in breast cancer: From new targets to new therapies
Tiffany A. Katz et al.
ANNALS OF MEDICINE (2014)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
Epigenetic Targeting of Ovarian Cancer Stem Cells
Yinu Wang et al.
CANCER RESEARCH (2014)
Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications
Artur Veloso et al.
GENOME RESEARCH (2014)
Predicting response to epigenetic therapy
Marianne B. Treppendahl et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Harnessing the potential of epigenetic therapy to target solid tumors
Nita Ahuja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Clinical development of demethylating agents in hematology
Shyamala C. Navada et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons
Iris Jonkers et al.
ELIFE (2014)
Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
Kunle Odunsi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes
Adam Blattler et al.
GENOME BIOLOGY (2014)
GC skew at the 5′ and 3′ ends of human genes links R-loop formation to epigenetic regulation and transcription termination
Paul A. Ginno et al.
GENOME RESEARCH (2013)
Histone methyltransferase SETD2 coordinates FACT recruitment with nucleosome dynamics during transcription
Silvia Carvalho et al.
NUCLEIC ACIDS RESEARCH (2013)
UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9
Xiaoli Liu et al.
NATURE COMMUNICATIONS (2013)
Software for Computing and Annotating Genomic Ranges
Michael Lawrence et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes
James P. Reddington et al.
GENOME BIOLOGY (2013)
CpGassoc: an R function for analysis of DNA methylation microarray data
Richard T. Barfield et al.
BIOINFORMATICS (2012)
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
Hsing-Chen Tsai et al.
CANCER CELL (2012)
DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival
Daniel D. De Carvalho et al.
CANCER CELL (2012)
Epigenetic Resensitization to Platinum in Ovarian Cancer
Daniela Matei et al.
CANCER RESEARCH (2012)
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
Christopher G. Duncan et al.
GENOME RESEARCH (2012)
Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA
Aaron L. Statham et al.
GENOME RESEARCH (2012)
Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk
Arie B. Brinkman et al.
GENOME RESEARCH (2012)
Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2
Weihong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
R-Loop Formation Is a Distinctive Characteristic of Unmethylated Human CpG Island Promoters
Paul A. Ginno et al.
MOLECULAR CELL (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
Matko Kalac et al.
BLOOD (2011)
Phase 1b-2a Study to Reverse Platinum Resistance Through Use of a Hypomethylating Agent, Azacitidine, in Patients With Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
Siqing Fu et al.
CANCER (2011)
DNA Methylation and SETDB1/H3K9me3 Regulate Predominantly Distinct Sets of Genes, Retroelements, and Chimeric Transcripts in mESCs
Mohammad M. Karimi et al.
CELL STEM CELL (2011)
CpG islands and the regulation of transcription
Aimee M. Deaton et al.
GENES & DEVELOPMENT (2011)
Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes
M. Y. Follo et al.
LEUKEMIA (2011)
Mapping and analysis of chromatin state dynamics in nine human cell types
Jason Ernst et al.
NATURE (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
Initiating RNA polymerase II and TIPs as hallmarks of enhancer activity and tissue-specificity
Frederic Koch et al.
TRANSCRIPTION-AUSTIN (2011)
5-azacytidine treatment reorganizes genomic histone modification patterns
Vitalina M. Komashko et al.
Epigenetics (2010)
The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation
Arunkumar Dhayalan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term Stability of Demethylation after Transient Exposure to 5-Aza-2′-Deoxycytidine Correlates with Sustained RNA Polymerase II Occupancy
Jacob D. Kagey et al.
MOLECULAR CANCER RESEARCH (2010)
Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET
Toshiyuki Matsui et al.
NATURE (2010)
Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme
Katan Patel et al.
NUCLEIC ACIDS RESEARCH (2010)
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
Tamer E. Fandy et al.
BLOOD (2009)
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
Michael T. McCabe et al.
CLINICAL CANCER RESEARCH (2009)
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D. Heintzman et al.
NATURE (2009)
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
Rafael A. Irizarry et al.
NATURE GENETICS (2009)
Azacytidine causes complex DNA methylation responses in myeloid leukemia
Carlo Stresemann et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation
John W. Edmunds et al.
EMBO JOURNAL (2008)
Role of nucleosornal occupancy in the epigenetic silencing of the MLH1 CpG island
Joy C. Lin et al.
CANCER CELL (2007)
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O. Soriano et al.
BLOOD (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
Pvclust: an R package for assessing the uncertainty in hierarchical clustering
R Suzuki et al.
BIOINFORMATICS (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Share Paper
